60
Identifying suitable T cells for cellular immunotherapy has so far been laborious and time-consuming. Scientists from the German Cancer Research Center (DKFZ) and the Mannheim University Medical Center want to simplify and speed up the process. Their new approach relies on high-throughput single-cell sequencing of immune cells from the patient’s tumor.
Those